IN-VITRO METHODS FOR ASSESSING HUMAN HEPATIC DRUG-METABOLISM - THEIR USE IN DRUG DEVELOPMENT

被引:166
作者
WRIGHTON, SA
VANDENBRANDEN, M
STEVENS, JC
SHIPLEY, LA
RING, BJ
RETTIE, AE
CASHMAN, JR
机构
[1] UNIV WASHINGTON, SCH PHARM, DEPT MED CHEM, SEATTLE, WA 98195 USA
[2] IGEN RES INST, SEATTLE, WA 98109 USA
关键词
D O I
10.3109/03602539308993982
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:453 / 484
页数:32
相关论文
共 113 条
[1]   A GENETIC-POLYMORPHISM OF THE N-OXIDATION OF TRIMETHYLAMINE IN HUMANS [J].
ALWAIZ, M ;
AYESH, R ;
MITCHELL, SC ;
IDLE, JR ;
SMITH, RL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (05) :588-594
[2]   SLOW OMEPRAZOLE METABOLIZERS ARE ALSO POOR S-MEPHENYTOIN HYDROXYLATORS [J].
ANDERSSON, T ;
REGARDH, CG ;
DAHLPUUSTINEN, ML ;
BERTILSSON, L .
THERAPEUTIC DRUG MONITORING, 1990, 12 (04) :415-416
[3]  
Ayesh R, 1988, BR J CLIN PHARM, V25, P664
[4]   INVITRO INHIBITION STUDIES OF TOLBUTAMIDE HYDROXYLASE-ACTIVITY OF HUMAN-LIVER MICROSOMES BY AZOLES, SULFONAMIDES AND QUINOLINES [J].
BACK, DJ ;
TJIA, JF ;
KARBWANG, J ;
COLBERT, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (01) :23-29
[5]   RELEVANCE OF GENETIC-POLYMORPHISM IN DRUG-METABOLISM IN THE DEVELOPMENT OF NEW DRUGS [J].
BALANT, LP ;
GUNDERTREMY, U ;
BOOBIS, AR ;
VONBAHR, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (06) :551-554
[6]   TECHNIQUES FOR PHARMACOLOGICAL AND TOXICOLOGICAL STUDIES WITH ISOLATED HEPATOCYTE SUSPENSIONS [J].
BERRY, MN ;
HALLS, HJ ;
GRIVELL, MB .
LIFE SCIENCES, 1992, 51 (01) :1-16
[7]   COMPARISON OF CAFFEINE METABOLISM BY SLICES, MICROSOMES AND HEPATOCYTE CULTURES FROM ADULT HUMAN-LIVER [J].
BERTHOU, F ;
RATANASAVANH, D ;
RICHE, C ;
PICART, D ;
VOIRIN, T ;
GUILLOUZO, A .
XENOBIOTICA, 1989, 19 (04) :401-417
[8]   HUMAN CYTOCHROMES-P-450 [J].
BOOBIS, AR ;
DAVIES, DS .
XENOBIOTICA, 1984, 14 (1-2) :151-185
[9]  
BRENDEL K, 1990, J AM COLL TOXICOL, V9, P621, DOI 10.3109/10915819009078767
[10]   CLINICAL-SIGNIFICANCE OF THE SPARTEINE-DEBRISOQUINE OXIDATION POLYMORPHISM [J].
BROSEN, K ;
GRAM, LF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (06) :537-547